Biodistribution and therapeutic effects in orthotopic osteosarcoma mouse model Based on these promising findings, the biosafety of Ru(II)-OH, NP2, or NP4 at a doses of 2 mg Ru/kg was studied upon intravenous injection into the tail vein of healthy female mice on the days 1, 4, and 7
A 0.50 mg dose = 0.50 ml = 50 units
However, in circumstances of high stress, environmental pollution or gastrointestinal problems, an undersupply can emerge
Tesofensine appears in research contexts involving monoamine transporter research, CNS pathway models, metabolic/neurochemical studies
Current cardiovascular guidance recognizes apolipoprotein B, lipoprotein(a), hs-CRP, and elevated triglycerides as markers that may help refine a persons atherosclerotic cardiovascular risk